1.
J Antibiot (Tokyo)
; 48(11): 1299-303, 1995 Nov.
Article
in English
| MEDLINE
| ID: mdl-8557572
ABSTRACT
Rifampicin (I) was converted into two inactivated products RIP-Ma and RIP-Mb by Mycobacterium smegmatis DSM43756. MS, NMR and chromatographic analysis showed the compounds to be 3-formyl-23-[O-(alpha-D-ribofuranosyl)]rifamycin SV (6) and 23-[O-(alpha-D-ribofuranosyl)]rifampicin (7), respectively.